PA
BNTX icon

Pinnacle Associates’s BioNTech BNTX Stock Holding History

Pinnacle Associates’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-885
Closed -$228K – 790
2021
Q4 		$228K Sell
885
-7,427
-89% -$2.03M ﹤0.01% 735
2021
Q3 		$2.27M Buy
8,312
+2,517
+43% +$800K 0.04% 321
2021
Q2 		$1.3M Hold
5,795
– – 0.02% 394
2021
Q1 		$633K Hold
5,795
– – 0.01% 496
2020
Q4 		$472K Buy
+5,795
New +$569K 0.01% 527

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Pinnacle Associates's BNTX Position: Q1 2022 in Review

Pinnacle Associates sold out of BioNTech (BNTX) in Q1 2022, closing a stake of 885 shares — an estimated $228K sold.

Pinnacle Associates first reported a position in BNTX in Q4 2020 and held it in 5 quarters. The position peaked at $2.27M in Q3 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

  • Pinnacle Associates reported no remaining BioNTech position as of Q1 2022 after selling out during the quarter.
  • Pinnacle Associates sold 885 BioNTech shares in Q1 2022, an estimated $228K.
  • Pinnacle Associates first reported a position in BioNTech in Q4 2020 and held it in 5 quarters.
  • Pinnacle Associates's BioNTech position peaked at $2.27M in Q3 2021.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on Pinnacle Associates's 13F filing for Q1 2022, filed 5 May 2022.